MALDI-TOF mass spectrometry in the clinical mycology laboratory: Identification of fungi and beyond

Expert Review of Proteomics

Volumn 10, Issue 2, 2013, Pages 151-164

  Posteraro, Brunella ^a   De Carolis, Elena ^a   Vella, Antonietta ^a   Sanguinetti, Maurizio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

andromas; antifungal susceptibility testing; fungal identification; fungal strain typing; intact cell mass spectrometry; MALDI Biotyper; SARAMIS ; Vitek mass spectrometry

Indexed keywords

ANTIFUNGAL SUSCEPTIBILITY; ASPERGILLOSIS; BLOOD CULTURE; CANDIDIASIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FUNGAL DETECTION; FUNGAL STRAIN; FUNGEMIA; FUNGUS IDENTIFICATION; FUSARIOSIS; HUMAN; LABORATORY DIAGNOSIS; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOULD; MYCOLOGY; ORGANISM COLONY; REVIEW; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION; YEAST; ZYGOMYCOSIS;

ANTIFUNGAL AGENTS; CLINICAL LABORATORY TECHNIQUES; FUNGI; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; MYCOLOGY; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YEASTS;

FUNGI;

EID: 84876103097     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.13.8     Document Type: Review

References (109)

1. Kliem M, Sauer S. The essence on mass spectrometry based microbial diagnostics. Curr. Opin. Microbiol. 15(3), 397-402 (2012
2. Murray PR. What is new in clinical microbiology-microbial identification by MALDI-TOF mass spectrometry: A paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J. Mol. Diagn. 14(5), 419-423 (2012
3. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Manual of Clinical Microbiology (10th Edition). ASM Press, Washington, DC, USA (2011
4. Sibley CD, Peirano G, Church DL. Molecular methods for pathogen and microbial community detection and characterization: Current and potential application in diagnostic microbiology. Infect. Genet. Evol. 12(3), 505-521 (2012
5. Weile J, Knabbe C. Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal. Bioanal. Chem. 394(3), 731-742 (2009
6. Freiwald A, Sauer S. Phylogenetic classification and identification of bacteria by mass spectrometry. Nat. Protoc. 4(5), 732-742 (2009
7. Seng P, Drancourt M, Gouriet F et al. Ongoing revolution in bacteriology: Routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49(4), 543-551 (2009
8. Dubois D, Grare M, Prere MF, Segonds C, Marty N, Oswald E. Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J. Clin. Microbiol. 50(8), 2568-2576 (2012
9. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: A bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J. Clin. Microbiol. 50(10), 3301-3308 (2012
10. Verroken A, Janssens M, Berhin C et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species. J. Clin. Microbiol. 48(11), 4015-4021 (2010
11. Lagacé-Wiens PR, Adam HJ, Karlowsky JA et al. Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: Analysis of performance, cost, and turnaround time. J. Clin. Microbiol. 50(10), 3324-3328 (2012
12. Havlicek V, Lemr K, Schug KA. Current trends in microbial diagnostics based on mass spectrometry. Anal. Chem. 85(2), 790-797 (2013
13. Fenselau C, Demirev PA. Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom. Rev. 20(4), 157-171 (2001
14. Sauer S, Kliem M. Mass spectrometry tools for the classification and identification of bacteria. Nat. Rev. Microbiol. 8(1), 74-82 (2010
15. Croxatto A, Prod'hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol. Rev. 36(2), 380-407 (2012
16. van Veen SQ, Claas EC, Kuijper EJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48(3), 900-907 (2010
17. Dieckmann R, Helmuth R, Erhard M, Malorny B. Rapid classification and identification of salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionizationtime of flight mass spectrometry. Appl. Environ. Microbiol. 74(24), 7767-7778 (2008
18. Dieckmann R, Strauch E, Alter T. Rapid identification and characterization of Vibrio species using whole-cell MALDITOF mass spectrometry. J. Appl. Microbiol. 109(1), 199-211 (2010
19. Welker M, Moore ER. Applications of whole-cell matrix-assisted laser-desorption/ ionization time-of-flight mass spectrometry in systematic microbiology. Syst. Appl. Microbiol. 34(1), 2-11 (2011
20. Sauer S, Freiwald A, Maier T et al. Classification and identification of bacteria by mass spectrometry and computational analysis. PLoS ONE 3(7), e2843 (2008
21. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin. Microbiol. Infect. 16(11), 1604-1613 (2010
22. Bille E, Dauphin B, Leto J et al. MALDITOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin. Microbiol. Infect. 18(11), 1117-1125 (2012
23. Vermeulen E, Verhaegen J, Indevuyst C, Lagrou K. Update on the evolving role of MALDI-TOF MS for laboratory diagnosis of fungal infections. Curr. Fungal Infect. Rep. 6(3), 206-214 (2012
24. Alanio A, Beretti JL, Dauphin B et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin. Microbiol. Infect. 17(5), 750-755 (2011
25. Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin. Microbiol. Infect. 16(11), 1614-1619 (2010
26. Seng P, Rolain JM, Fournier PE, La Scola B, Drancourt M, Raoult D. MALDI-TOFmass spectrometry applications in clinical microbiology. Future Microbiol. 5(11), 1733-1754 (2010
27. Cherkaoui A, Hibbs J, Emonet S et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48(4), 1169-1175 (2010
28. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J. Clin. Microbiol. 48(5), 1549-1554 (2010
29. Steensels D, Verhaegen J, Lagrou K. Matrix-assisted laser desorption ionizationtime of flight mass spectrometry for the identification of bacteria and yeasts in a clinical microbiological laboratory: A review. Acta Clin. Belg. 66(4), 267-273 (2011
30. de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi (2nd Edition). Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands (2000). Rev. Proteomics 10(2), (2013) Review
31. Lass-Flörl C. Zygomycosis: Conventional laboratory diagnosis. Clin. Microbiol. Infect. 15(Suppl. 5), 60-65 (2009
32. Posteraro B, Torelli R, De Carolis E, Posteraro P, Sanguinetti M. Update on the laboratory diagnosis of invasive fungal infections. Mediterr. J. Hematol. Infect. Dis. 3(1), e2011002 (2011
33. Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52(3), 197-205 (2009
34. Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: Zygomycosis. Clin. Microbiol. Infect. 15(Suppl. 5), 10-14 (2009
35. Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: Update 2012. Diagn. Microbiol. Infect. Dis. 73(4), 293-300 (2012
36. Arendrup MC. Epidemiology of invasive candidiasis. Curr. Opin. Crit. Care 16(5), 445-452 (2010
37. Erjavec Z, Kluin-Nelemans H, Verweij PE. Trends in invasive fungal infections, with emphasis on invasive aspergillosis. Clin. Microbiol. Infect. 15(7), 625-633 (2009
38. Skiada A, Pagano L, Groll A et al.; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin. Microbiol. Infect. 17(12), 1859-1867 (2011
39. Muhammed M, Coleman JJ, Carneiro HA, Mylonakis E. The challenge of managing fusariosis. Virulence 2(2), 91-96 (2011
40. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am. J. Med. 125(Suppl. 1), S14-S24 (2012
41. Meletiadis J, Arabatzis M, Bompola M et al. Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates. J. Clin. Microbiol. 49(7), 2722-2727 (2011
42. Santos C, Paterson RR, Venâncio A, Lima N. Filamentous fungal characterizations by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J. Appl. Microbiol. 108(2), 375-385 (2010
43. Chen SC, Marriott D, Playford EG et al.; Australian Candidaemia Study. Candidaemia with uncommon Candida species: Predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin. Microbiol. Infect. 15(7), 662-669 (2009
44. Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev. Iberoam. Micol. 25(1), S4-S12 (2008
45. Bader O. MALDI-TOF-MS-based species identification and typing approaches in medical mycology. Proteomics 13(5), 788-799 (2012
46. Amiri-Eliasi B, Fenselau C. Characterization of protein biomarkers desorbed by MALDI from whole fungal cells. Anal. Chem. 73(21), 5228-5231 (2001
47. Pinto A, Halliday C, Zahra M et al. Matrix-assisted laser desorption ionizationtime of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS ONE 6(10), e25712 (2011
48. El Khéchine A, Couderc C, Flaudrops C, Raoult D, Drancourt M. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice. PLoS ONE 6(9), e24720 (2011
49. Goyer M, Lucchi G, Ducoroy P, Vagner O, Bonnin A, Dalle F. Optimization of the preanalytical steps of matrix-assisted laser desorption ionization-time of flight mass spectrometry identification provides a flexible and efficient tool for identification of clinical yeast isolates in medical laboratories. J. Clin. Microbiol. 50(9), 3066-3068 (2012
50. Iriart X, Lavergne RA, Fillaux J et al. Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy. J. Clin. Microbiol. 50(6), 2107-2110 (2012
51. Qian J, Cutler JE, Cole RB, Cai Y. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal. Bioanal. Chem. 392(3), 439-449 (2008
52. Cassagne C, Cella AL, Suchon P, Normand AC, Ranque S, Piarroux R. Evaluation of four pretreatment procedures for MALDITOF MS yeast identification in the routine clinical laboratory. Med. Mycol. doi:10.1016/j.mycmed.2012.07.034 (2012) (Epub ahead of print
53. Haigh J, Degun A, Eydmann M, Millar M, Wilks M. Improved performance of bacterium and yeast identification by a commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry system in the clinical microbiology laboratory. J. Clin. Microbiol. 49(9), 3441 (2011
54. Welker M. Proteomics for routine identification of microorganisms. Proteomics 11(15), 3143-3153 (2011
55. Cassagne C, Ranque S, Normand AC et al. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. PLoS ONE 6(12), e28425 (2011
56. Hettick JM, Green BJ, Buskirk AD et al. Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Rapid Commun. Mass Spectrom. 22(16), 2555-2560 (2008
57. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49(4), 1614-1616 (2011
58. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17(9), 1359-1365 (2011
59. Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. Evaluation of matrix-assisted laser desorption ionizationtime of flight mass spectrometry for identification of clinically important yeast species. J. Clin. Microbiol. 48(10), 3482-3486 (2010
60. Marklein G, Josten M, Klanke U et al. Matrix-assisted laser desorption ionizationtime of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47(9), 2912-2917 (2009
61. Desnos-Ollivier M, Ragon M, Robert V, Raoux D, Gantier JC, Dromer F. Posteraro, De Carolis, Vella & Sanguinetti Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii). J. Clin. Microbiol. 46(10), 3237-3242 (2008
62. Jensen RH, Arendrup MC. Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J. Clin. Microbiol. 49(2), 549-556 (2011
63. Santos C, Lima N, Sampaio P, Pais C. Matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry to detect emerging pathogenic Candida species. Diagn. Microbiol. Infect. Dis. 71(3), 304-308 (2011
64. McTaggart LR, Lei E, Richardson SE, Hoang L, Fothergill A, Zhang SX. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49(8), 3050-3053 (2011
65. Van Herendael BH, Bruynseels P, Bensaid M et al. Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDITOF MS). Eur. J. Clin. Microbiol. Infect. Dis. 31(5), 841-848 (2012
66. Rosenvinge FS, Dzajic E, Knudsen E et al. Performance of matrix-assisted laser desorption-time of flight mass spectrometry for identification of clinical yeast isolates. Mycoses doi:10.1111/myc.12000 (2012) (Epub ahead of print
67. Theel ES, Schmitt BH, Hall L et al. Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50(9), 3093-3095 (2012
68. Garey KW, Rege M, Pai MP et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin. Infect. Dis. 43(1), 25-31 (2006
69. Bassetti M, Trecarichi EM, Righi E et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn. Microbiol. Infect. Dis. 58(3), 325-331 (2007
70. Tumbarello M, Posteraro B, Trecarichi EM et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45(6), 1843-1850 (2007
71. Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit. Care Med. 40(12), 3277-3282 (2012
72. Drancourt M. Detection of microorganisms in blood specimens using matrixassisted laser desorption ionization time-of-flight mass spectrometry: A review. Clin. Microbiol. Infect. 16(11), 1620-1625 (2010
73. Ferroni A, Suarez S, Beretti JL et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48(5), 1542-1548 (2010
74. Marinach-Patrice C, Fekkar A, Atanasova R et al. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS ONE 5(1), e8862 (2010
75. Yan Y, He Y, Maier T et al. Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system. J. Clin. Microbiol. 49(7), 2528-2532 (2011
76. Schubert S, Weinert K, Wagner C et al. Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. J. Mol. Diagn. 13(6), 701-706 (2011
77. Ferreira L, Sánchez-Juanes F, Porras-Guerra I et al. Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 17(4), 546-551 (2011
78. Spanu T, Posteraro B, Fiori B et al. Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: An observational study in two large microbiology laboratories. J. Clin. Microbiol. 50(1), 176-179 (2012
79. Balajee SA, Borman AM, Brandt ME et al. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: Where are we and where should we go from here? J. Clin. Microbiol. 47(4), 877-884 (2009
80. Welham KJ, Domin MA, Johnson K, Jones L, Ashton DS. Characterization of fungal spores by laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 14(5), 307-310 (2000
81. Li TY, Liu BH, Chen YC. Characterization of Aspergillus spores by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 14(24), 2393-2400 (2000
82. Valentine NB, Wahl JH, Kingsley MT, Wahl KL. Direct surface analysis of fungal species by matrix-assisted laser desorption/ ionization mass spectrometry. Rapid Commun. Mass Spectrom. 16(14), 1352-1357 (2002
83. Chen HY, Chen YC. Characterization of intact Penicillium spores by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 19(23), 3564-3568 (2005
84. Kemptner J, Marchetti-Deschmann M, Mach R, Druzhinina IS, Kubicek CP, Allmaier G. Evaluation of matrix-assisted laser desorption/ionization (MALDI) preparation techniques for surface characterization of intact Fusarium spores by MALDI linear time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 23(6), 877-884 (2009
85. Dong H, Kemptner J, Marchetti-Deschmann M, Kubicek CP, Allmaier G. Development of a MALDI two-layer volume sample preparation technique for analysis of colored conidia spores of Fusarium by MALDI linear TOF mass spectrometry. Anal. Bioanal. Chem. 395(5), 1373-1383 (2009
86. Hettick JM, Green BJ, Buskirk AD et al. Discrimination of Aspergillus isolates at the species and strain level by matrixassisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Anal. Biochem. 380(2), 276-281 (2008
87. Erhard M, Hipler UC, Burmester A, Brakhage AA, Wöstemeyer J. Identification of dermatophyte species causing onychomycosis and tinea pedis by MALDI-TOF mass spectrometry. Exp. Dermatol. 17(4), 356-361 (2008
88. De Carolis E, Posteraro B, Lass-Flörl C et al. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Microbiol. Infect. 18(5), 475-484 (2012
89. Nenoff P, Erhard M, Simon JC et al. MALDI-TOF mass spectrometry- a rapid method for the identification of dermato- MALDI-TOF mass spectrometry in the clinical mycology laboratory phyte species. Med. Mycol. 51(1), 17-24 (2013
90. Marinach-Patrice C, Lethuillier A, Marly A et al. Use of mass spectrometry to identify clinical Fusarium isolates. Clin. Microbiol. Infect. 15(7), 634-642 (2009
91. Coulibaly O, Marinach-Patrice C, Cassagne C, Piarroux R, Mazier D, Ranque S. Pseudallescheria/Scedosporium complex species identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Med. Mycol. 49(6), 621-626 (2011
92. Theel ES, Hall L, Mandrekar J, Wengenack NL. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49(12), 4067-4071 (2011
93. Schrödl W, Heydel T, Schwartze VU et al. Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionizationtime of flight analyzer-mediated mass spectrometry. J. Clin. Microbiol. 50(2), 419-427 (2012
94. Del Chierico F, Masotti A, Onori M et al. MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin. J. Proteomics 75(11), 3314-3330 (2012
95. Alshawa K, Beretti JL, Lacroix C et al. Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 50(7), 2277-2281 (2012
96. Bruker Daltonics. Fungi Library- MALDI Biotyper. Bruker Daltonics, MA, USA (2012
97. Lau AF, Drake SK, Calhoun LB, Henderson CM, Zelazny AM. Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 51(3), 828-834 (2013
98. Sulc M, Peslova K, Zabka M, Hajduch M, Havlicek V. Biomarkers of Aspergillus spores: Dtrain typing and protein identification. Int. J. Mass Spectrom. 280, 162-168 (2009
99. Pulcrano G, Roscetto E, Iula VD, Panellis D, Rossano F, Catania MR. MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units. Eur. J. Clin. Microbiol. Infect. Dis. 31(11), 2919-2928 (2012
100. Hof H, Eigner U, Maier T, Staib p. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometry. Clin. Lab. 58(9-10), 927-931 (2012
101. Posteraro B, Vella A, Cogliati M et al. Matrix-assisted laser desorption ionizationtime of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J. Clin. Microbiol. 50(7), 2472-2476 (2012
102. Firacative C, Trilles L, Meyer W. MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS ONE 7(5), e37566 (2012
103. Samson RA, Varga J. What is a species in Aspergillus? Med. Mycol. 47(Suppl. 1), S13-S20 (2009
104. Gibbons JG, Salichos L, Slot JC et al. The evolutionary imprint of domestication on genome variation and function of the filamentous fungus Aspergillus oryzae. Curr. Biol. 22(15), 1403-1409 (2012
105. De Carolis E, Vella A, Florio AR et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species. J. Clin. Microbiol. 50(7), 2479-2483 (2012
106. Marinach C, Alanio A, Palous M et al. MALDI-TOF MS-based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole. Proteomics 9(20), 4627-4631 (2009
107. Tumbarello M, Sanguinetti M, Trecarichi EM et al. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: Risk factors, antifungal treatment and outcome. J. Antimicrob. Chemother. 62(6), 1379-1385 (2008
108. Degenkolb T, von Döhren H, Nielsen KF, Samuels GJ, Brückner H. Recent advances and future prospects in peptaibiotics, hydrophobin, and mycotoxin research, and their importance for chemotaxonomy of Trichoderma and Hypocrea. Chem. Biodivers. 5(5), 671-680 (2008
109. Ferreira L, Sánchez-Juanes F, Muñoz-Bellido JL, González-Buitrago JM. Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: Intact cell vs. extraction method. Clin. Microbiol. Infect. 17(7), 1007-1012 (2011